MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Model Number ETLW1620C124E |
Device Problems
Leak/Splash (1354); Migration or Expulsion of Device (1395)
|
Patient Problem
Abdominal Pain (1685)
|
Event Date 04/08/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
Continuation of d10: section d information references the main component of the system.Other relevant device(s) are: product id: e tbf3220c166e, serial/lot #: (b)(6), ubd: 12-mar-2021, udi#: (b)(4).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
An endurant ii stent graft (etbf3220c166e) and endurant limb (etlw1620c124e) were implanted during the endovascular treatment of a 7 8mm abdominal aortic aneurysm.It was reported approximately 5 years post the index procedure, the patient presented emergently experiencing abdominal pain.A ct scan revealed that both the limbs had pulled into the aneurysm sac causing bilateral type ib endoleaks in etbf3220c166e & e tlw1620c124e. intervention was performed and two additional endurant ii stent graft limbs (etlw1620c156) implanted on the right and (etlw1624c156e) placed on the left were successfully extended to the hypogastric resolving the type ib endoleak. per the physician the cause of the type ib endoleaks was anatomy related due to the patients short common iliac.No additional clinical sequalae were provided and the patient is fine.
|
|
Manufacturer Narrative
|
Film evaluation summary: the reported bilateral type ib endoleak and migration were confirmed on the films provided.Stent migration into the aneurysm sac was most likely a factor in the type ib endoleak, however, the cause of the migration could not be determined from the available films.Lack of pre-implant cts did not allow for assessment of the pre-implant anatomy and earlier pots-implant cts were not available for comparison of the stent graft configuration over time.It is possible that disease progression with aneurysm morphology changes and loss of seal over the duration of implantation of the devices associated with the reported short common iliac arteries may have been a factor in the occurrence of the observed events.Analysis of the returned films did not reveal any out of specification stent graft integrity issues.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|